688131 皓元医药
2023/06 - 中期2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)3.9969.35016.25327.69325.435
总资产报酬率 ROA (%)2.5056.47411.78418.35617.340
投入资产回报率 ROIC (%)2.8947.55513.86322.77122.380

边际利润分析
销售毛利率 (%)50.08851.44454.11856.67457.180
营业利润率 (%)12.64214.47421.64123.41220.633
息税前利润/营业总收入 (%)13.42114.57722.26124.78720.757
净利润/营业总收入 (%)10.65614.10519.66220.22317.955

收益指标分析
经营活动净收益/利润总额(%)128.875107.449109.025113.942106.093
价值变动净收益/利润总额(%)-1.0938.085-0.0570.9780.759
营业外收支净额/利润总额(%)-1.1750.995-0.111-0.051-0.030

偿债能力分析
流动比率 (X)1.9772.2174.9442.1603.440
速动比率 (X)0.8101.1093.8491.3842.226
资产负债率 (%)38.65535.18322.98638.40126.314
带息债务/全部投入资本 (%)22.39415.3670.69518.8093.854
股东权益/带息债务 (%)310.549492.78912,717.344405.3432,380.148
股东权益/负债合计 (%)157.979183.280332.471160.412280.020
利息保障倍数 (X)14.496-342.76634.56917.871159.546

营运能力分析
应收账款周转天数 (天)78.23463.74341.66837.54240.120
存货周转天数 (天)429.831344.748235.069247.717276.630